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Mortality has fallen for many of neurological conditions in childhood, which has exposed the 
need for data on morbidity and its predictors, particularly if it may be preventable, e.g. with 
vaccination for infectious disease.1 The economic cost of chronic neurological conditions in 
childhood is very substantial. In addition to the cost of acute treatment and rehabilitation for 
those who need it, e.g. after traumatic brain injury (TBI) or stroke,2 life expectancy, although 
reduced, may be much closer to that of the typically developing child than many physicians 
appreciate.3, 4 The conditions in this section on neuro-developmental disorders typically come 
on relatively suddenly in child with or without previous problems and have a cost in terms of 
cognition in a substantial proportion of the patients. For an initial presentation with epilepsy 
in the clinic, just as for acute presentation with, in- or out-of-hospital cardiac arrest, stroke, or 
neurological complications of essential treatment, such as brain tumor or cardiopulmonary 
bypass, the first question that parents and physicians want answered is “How is s/he going to 
be in the long term?” The family then want to know what can be done to optimise outcome 
for their own child. If the attending physicians cannot supply answers to either of these 
questions, they usually turn to alternative sources of information from social media, including 
family support groups as well as the internet. Despite this high level of anxiety for all those 
involved, especially if there may be a medicolegal claim in countries where no-fault 
compensation5 is not available, there has been a paucity of long-term outcome data to inform 
conversations with families and to act as endpoints in essential trials of treatment.   
 
Recently in a number of areas there has been a focus on cognitive outcomes and the papers in 
this section represent an attempt to pull this literature together to encourage debate and, 
ideally, appropriate funding for adequately powered studies which involve not only 
observation of the natural history but appropriate trials of management.  For some conditions, 
such as paediatric stroke, to the professional the initial cognitive outcome may look relatively 
good, and there is some evidence for better outcome than for the elderly adult for the same 
extent of injury perhaps related to “plasticity” but children may “grow into” certain deficits.6 
There are very few data on whether physical or cognitive rehabilitation improves outcome or 
even has a detrimental effect7 so the planning and conduct of randomized controlled trials is 
very welcome; it will be essential to avoid publication bias in favour of those suggesting a 
positive effect. In pediatric stroke, the actual infarct may be small or large and may occur at a 
very early age or in a teenager and these may have important effects on outcome, as 
Greenham et al point out.8 Site of neuroimaging abnormality is not necessarily a predictor of 
outcome in acute neurological conditions but, as Catsman-Berrevoets discusses,9 recent 
studies in cerebellar mutism suggest more widespread abnormality, at least acutely, and this 
may be worth investigation with novel neuroimaging techniques in all causes of cognitive 
difficulties associated with acute neurological presentation. 
 
For children with epilepsy it is clear that cognition is often affected before the onset of 
seizures even in children with no obvious genetic or neuro-imaging cause for their seizures.  
In addition, as outlined by Braun,10 the combination of clinical and sub-clinical seizures and 
the drugs used to treat may have a combined effect on cognitive outcome which is often 
difficult to monitor if clinics are spaced at six month intervals.   
 
For children with global insults such as head injury, encephalitis or meningitis, the prognosis 
is often thought to be poor, as Kirkham discusses,11 but in fact many of these children do 
surprisingly well and it is important to consider etiology before making any prognostic 
predictions. For example, in children with meningococcal meningitis, although they may 
often lose limbs, cerebral infarction is very rare, whereas in pneumococcal meningitis arterial 
or venous stroke may affect up to 50%, making this a focal as well as a global injury. 
Seizures and status epilepticus are associated with poor outcome in many etiologies of coma. 
Intensive care management requires sedation and sometimes therapeutic paralysis so clinical 
seizures may not be manifest. There has been considerable controversy about the importance 
of electrographic seizures in predicting outcome, and more importantly, on how they can be 
most appropriately managed, but the data set out in Hahn’s contribution suggests that this 
should be an important priority.12 
 
Understanding the previous literature is important as we move forward to the era of 
expensive international randomised control trials.  To reduce cost it is often tempting to 
document a simple outcome scale and indeed even when IQ or executive function have been 
collected, they may not be published because the whole team has moved on. There are 
methodological concerns about data already published, for example reporting of the number 
of assessors and their training,13 but these issues are not likely to put a child with apparently 
poor outcome into a good outcome group. One way forward may be to collect routine 
academic data eg., the results of SATs in the UK, as these are standardised and reflect the 
real world in terms of work opportunities as well as educational attainment. It may then be 
possible to assess outcomes and the results of introduction of new interventions, such as 
vaccination or effective Pedaitric Intensive Transport and Care, on a population basis in a 
timely fashion. 
   
There are very few data on cognitive rehabilitation in children despite the now dazzling array 
of apps for phone and tablet as well as computer which can be used to practice cognitive 
skills including language, attention and processing speed. Interventions to enable families to 
work with children and adolescents on their behavioural issues, which are likely to improve 
social participation, are also likely to be important. However, there are generic barriers to 
self-management via telemedicine14 which may limit availability despite the attraction of low 
cost to funders. There is now real hope of improvement in acute management and cognitive 
rehabilitation for children, families and physicians. 
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